Get started
Author

Nil Navarro-Gorro

Observed names: N. Navarro-Gorro, Nil Navarro Gorro
ORCID: 0000-0003-4633-9205
Observed ORCID: 0000-0003-4633-9205
OpenAlex ID: A5087336773
Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockade
2025 · Pedro Rocha, Rafael Bach, et al. · OncoImmunology · 9
Induction avelumab followed by chemoimmunotherapy and maintenance versus chemotherapy alone as first-line therapy in cis-ineligible metastatic urothelial carcinoma (INDUCOMAIN): a randomized phase II study
2024 · A. Rodriguez-Vida, B.P. Valderrama, et al. · ESMO Open · 2
Efficacy and safety of the DLL3/CD3 T-cell engager obrixtamig in patients with genitourinary extrapulmonary neuroendocrine carcinomas with high or low DLL3 expression: Results from an ongoing phase I trial.
2026 · Nil Navarro-Gorro, Jaume Capdevila, et al. · Journal of Clinical Oncology · 1
225P: Circulating tumor DNA as a prognostic biomarker in unresectable locally advanced NSCLC
2025 · N. Navarro-Gorro, L. Masfarre Pinto, et al. · Journal of Thoracic Oncology · 1
PDF
383P: KRAS G12C vs. non-G12C non-small cell lung cancer (NSCLC): Insights from gene expression analysis
2025 · L. Masfarre Pinto, S. Clave, et al. · Journal of Thoracic Oncology · 1
PDF
Immune checkpoint inhibitor-related myocarditis, myositis, and myasthenia gravis overlap syndrome: a single-center case series and systematic review
2026 · Jorge Soriano, Miguel Martínez-Rubiño, et al. · Supportive Care in Cancer
Clinical outcomes of KRAS G12C versus non-G12C mutant NSCLC treated with immunotherapy: a multicentre real-world study
2026 · Laura Masfarré, Ana Sofia Parreira, et al. · Lung Cancer
PDF
Real-world data of enfortumab vedotin in patients with advanced urothelial cancer in Spain: The ENFANTS-GUARD study.
2026 · Jorge Esteban Villarrubia, Maria Jose Juan Fita, et al. · Journal of Clinical Oncology
PDF
P3.03I.12 Modulation of EMT Increases the Activity of Lurbinectedin in Small Cell Lung Cancer
2024 · A. Iñañez, R. del Rey-Vergara, et al. · Journal of Thoracic Oncology
PDF
P2.11A.08 Molecular and Immunological Features Associated with Long-Term Benefit in Metastatic NSCLC Patients Undergoing Immune Checkpoint Blockade
2024 · P. Rocha, R. Bach, et al. · Journal of Thoracic Oncology
PDF
6005-8. Cuando El Tumor Alcanza El Corazón: Serie De Casos De Metástasis Cardiacas
2024 · Anna García Alonso, Miren Vicente Elcano, et al. · Revista Española de Cardiología
EP14.05-002 Impact of Body Mass Index on Survival in Patients with Small Cell Lung Cancer
2022 · A. Rios-Hoyo, L. Masfarré, et al. · Journal of Thoracic Oncology
167P KRAS G12C lung adenocarcinoma represents a distinct group of patients with different response to immunotherapy
2022 · L. Masfarré, P. Rocha, et al. · Annals of Oncology
91P Preexisting tumor host immunity delineates clinical outcomes in resectable non-small cell lung cancer
2022 · P. Rocha, M. Rodrigo, et al. · Annals of Oncology
PDF
Works count: 14
Citation count: 14
H-index: 2
I10-index:
Year
Topic
Type